Loading...

Royalty Pharma plc Peer Comparison

Metric Value Ranking
Market Cap $14.0 Billion 2/18 BGNE
$20.2B
RPRX
$14.0B
KRTX
$12.6B
ASND
$8.6B
MDGL
$7.4B
BPMC
$6.0B
ISEE
$5.5B
MRTX
$4.1B
APLS
$3.4B
IOVA
$1.7B
DAWN
$1.2B
ADPT
$1.2B
DNA
$846.7M
CVAC
$818.7M
KNTE
$125.0M
RPHM
$60.8M
IKNA
$60.0M
OCEA
$4.5M
Gross Margin 100% 1/18 RPRX
100%
BPMC
98%
MDGL
97%
CVAC
96%
ASND
92%
DAWN
92%
MRTX
91%
DNA
89%
BGNE
83%
APLS
81%
ADPT
64%
IOVA
32%
ISEE
0%
KRTX
0%
KNTE
0%
IKNA
0%
RPHM
0%
OCEA
0%
Profit Margin 35% 3/18 DAWN
100%
CVAC
68%
RPRX
35%
ISEE
0%
KRTX
0%
KNTE
0%
IKNA
0%
RPHM
0%
OCEA
0%
BGNE
-12%
ASND
-22%
APLS
-33%
BPMC
-44%
DNA
-63%
ADPT
-69%
MRTX
-100%
IOVA
-100%
MDGL
-100%
EBITDA margin 61% 3/18 DAWN
148%
CVAC
76%
RPRX
61%
BGNE
-5%
ASND
-22%
BPMC
-26%
APLS
-38%
DNA
-62%
ADPT
-70%
ISEE
-100%
KRTX
-100%
KNTE
-100%
IKNA
-100%
RPHM
-100%
OCEA
-100%
IOVA
-152%
MDGL
-166%
MRTX
-1049%
Quarterly Revenue $594.0 Million 2/18 BGNE
$1.0B
RPRX
$594.0M
CVAC
$542.7M
ASND
$191.1M
APLS
$176.6M
BPMC
$128.2M
DNA
$89.0M
MDGL
$62.2M
IOVA
$58.6M
ADPT
$46.4M
DAWN
$20.1M
MRTX
$16.4M
ISEE
$0
KRTX
$0
KNTE
$0
IKNA
$0
RPHM
$0
OCEA
$0
Quarterly Earnings $208.0 Million 2/18 CVAC
$371.5M
RPRX
$208.0M
DAWN
$37.0M
RPHM
-$5.4M
OCEA
-$5.5M
IKNA
-$10.2M
KNTE
-$17.1M
ADPT
-$32.1M
ASND
-$42.3M
BPMC
-$56.3M
DNA
-$56.4M
APLS
-$57.4M
ISEE
-$70.6M
IOVA
-$83.5M
MDGL
-$107.0M
KRTX
-$113.8M
BGNE
-$121.4M
MRTX
-$161.9M
Quarterly Free Cash Flow $743.0 Million 1/18 RPRX
$743.0M
CVAC
$385.5M
BGNE
$54.7M
APLS
$34.1M
RPHM
-$0
OCEA
-$885,000
DAWN
-$5.0M
IKNA
-$8.9M
BPMC
-$13.7M
KNTE
-$17.4M
ADPT
-$27.4M
ISEE
-$50.8M
IOVA
-$61.3M
MDGL
-$62.8M
ASND
-$96.2M
KRTX
-$111.9M
DNA
-$118.6M
MRTX
-$143.7M
Trailing 4 Quarters Revenue $2.3 Billion 2/18 BGNE
$3.3B
RPRX
$2.3B
APLS
$675.9M
CVAC
$596.5M
BPMC
$434.4M
ASND
$399.8M
DNA
$218.0M
ADPT
$177.3M
IOVA
$90.9M
MDGL
$76.8M
MRTX
$38.2M
DAWN
$28.8M
RPHM
$734,000
IKNA
$659,000
KRTX
$654,000
ISEE
$0
KNTE
$0
OCEA
$0
Trailing 4 Quarters Earnings $858.8 Million 1/18 BGNE
$1.0B
RPRX
$594.0M
CVAC
$542.7M
ASND
$191.1M
APLS
$176.6M
BPMC
$128.2M
DNA
$89.0M
MDGL
$62.2M
IOVA
$58.6M
ADPT
$46.4M
DAWN
$20.1M
MRTX
$16.4M
ISEE
-$0
KRTX
-$0
KNTE
-$0
IKNA
-$0
RPHM
-$0
OCEA
-$0
Quarterly Earnings Growth -58% 16/18 CVAC
794%
DAWN
180%
DNA
81%
RPHM
73%
OCEA
61%
APLS
59%
BPMC
58%
ASND
56%
KNTE
43%
IKNA
41%
ADPT
36%
IOVA
27%
MRTX
7%
MDGL
-8%
KRTX
-49%
RPRX
-58%
ISEE
-104%
BGNE
-156%
Annual Earnings Growth 21% 7/18 CVAC
144%
BPMC
76%
APLS
51%
OCEA
50%
DAWN
50%
ASND
34%
RPRX
21%
DNA
21%
IKNA
13%
KNTE
9%
RPHM
9%
BGNE
7%
IOVA
5%
ADPT
-1%
MRTX
-2%
KRTX
-37%
MDGL
-46%
ISEE
-60%
Quarterly Revenue Growth 0% 10/18 IOVA
12385%
CVAC
2896%
MRTX
202%
BPMC
127%
APLS
78%
DNA
61%
BGNE
28%
ASND
26%
ADPT
22%
RPRX
0%
MDGL
0%
ISEE
0%
KNTE
0%
IKNA
0%
RPHM
0%
OCEA
0%
DAWN
0%
KRTX
-100%
Annual Revenue Growth 3% 8/18 IOVA
7580%
CVAC
1284%
BPMC
89%
MRTX
77%
APLS
76%
BGNE
29%
ASND
29%
RPRX
3%
MDGL
0%
ISEE
0%
KNTE
0%
RPHM
0%
OCEA
0%
DAWN
0%
ADPT
-4%
DNA
-27%
KRTX
-88%
IKNA
-89%
Cash On Hand $929.0 Million 2/18 BGNE
$2.7B
RPRX
$929.0M
DNA
$616.2M
ASND
$614.9M
CVAC
$605.3M
ISEE
$467.6M
DAWN
$422.8M
APLS
$396.9M
MRTX
$258.7M
MDGL
$232.7M
KRTX
$185.8M
IOVA
$164.2M
BPMC
$89.4M
KNTE
$57.0M
IKNA
$45.2M
ADPT
$38.1M
RPHM
$36.0M
OCEA
-$0
Short Term Debt $0 17/18 BGNE
$881.5M
ASND
$540.1M
BPMC
$45.0M
OCEA
$12.8M
IOVA
$11.6M
ADPT
$10.0M
MRTX
$8.0M
APLS
$6.8M
CVAC
$5.7M
IKNA
$3.9M
KRTX
$2.8M
KNTE
$892,000
MDGL
$878,000
ISEE
$774,000
RPHM
$331,000
DAWN
$77,000
RPRX
-$0
DNA
-$0
Long Term Debt $0 16/18 DNA
$445.6M
ASND
$401.2M
BPMC
$341.5M
BGNE
$220.0M
MDGL
$118.3M
APLS
$104.7M
ISEE
$97.0M
ADPT
$81.8M
IOVA
$66.4M
MRTX
$42.2M
CVAC
$38.3M
KRTX
$13.8M
IKNA
$4.5M
DAWN
$2.5M
RPHM
$492,000
RPRX
$0
KNTE
$0
OCEA
$0
PE 16.33 1/18 RPRX
16.33
CVAC
6.76
BGNE
-1.00
MRTX
-1.00
IOVA
-1.00
MDGL
-1.00
BPMC
-1.00
APLS
-1.00
ASND
-1.00
ADPT
-1.00
ISEE
-1.00
KRTX
-1.00
KNTE
-1.00
IKNA
-1.00
RPHM
-1.00
OCEA
-1.00
DAWN
-1.00
DNA
-1.00
PS 6.19 11/18 KRTX
19264.95
MRTX
107.82
MDGL
95.75
IKNA
91.02
RPHM
82.89
DAWN
42.90
ASND
19.63
IOVA
18.68
BPMC
13.82
ADPT
6.93
RPRX
6.19
BGNE
6.09
APLS
5.04
DNA
3.88
CVAC
1.25
ISEE
-1.00
KNTE
-1.00
OCEA
-1.00
PB 1.36 11/18 BPMC
19.17
APLS
14.37
ISEE
11.55
KRTX
10.05
MDGL
9.46
BGNE
5.88
ADPT
5.50
MRTX
4.35
DAWN
2.23
IOVA
2.19
RPRX
1.36
DNA
1.06
CVAC
1.03
RPHM
0.79
KNTE
0.78
IKNA
0.45
ASND
0.00
OCEA
0.00
PC 15.09 6/18 KRTX
67.80
BPMC
67.18
ADPT
32.28
MDGL
31.61
MRTX
15.92
RPRX
15.09
ASND
14.02
ISEE
11.79
IOVA
10.34
APLS
8.59
BGNE
7.48
DAWN
2.92
KNTE
2.19
RPHM
1.69
DNA
1.37
CVAC
1.35
IKNA
1.33
OCEA
-1.00
Liabilities to Equity 0.76 5/18 BPMC
2.83
APLS
2.80
ADPT
1.50
DNA
0.86
RPRX
0.76
BGNE
0.70
MDGL
0.38
ISEE
0.29
IOVA
0.28
MRTX
0.19
CVAC
0.18
IKNA
0.11
KNTE
0.09
DAWN
0.08
KRTX
0.07
RPHM
0.02
ASND
0.00
OCEA
0.00
ROA 0.05 2/18 CVAC
14%
RPRX
5%
BPMC
-11%
BGNE
-15%
DAWN
-15%
APLS
-28%
KRTX
-32%
ASND
-35%
ADPT
-35%
ISEE
-35%
IKNA
-40%
IOVA
-41%
DNA
-44%
MDGL
-48%
MRTX
-63%
KNTE
-64%
RPHM
-72%
OCEA
-2352%
ROE 0.08 4/18 ASND
394%
OCEA
27%
CVAC
17%
RPRX
8%
DAWN
-16%
BGNE
-25%
KRTX
-34%
BPMC
-41%
IKNA
-44%
ISEE
-45%
IOVA
-53%
MDGL
-67%
KNTE
-70%
RPHM
-74%
MRTX
-76%
DNA
-82%
ADPT
-87%
APLS
-105%
Current Ratio 2.31 12/18 RPHM
42.60
KRTX
16.30
DAWN
13.25
KNTE
12.16
IKNA
10.10
CVAC
6.60
MRTX
6.17
IOVA
4.55
ISEE
4.50
MDGL
3.62
BGNE
2.43
RPRX
2.31
DNA
2.17
ADPT
1.67
APLS
1.36
BPMC
1.35
ASND
0.92
OCEA
0.01
Quick Ratio 0.12 17/18 RPRX
16.33
CVAC
6.76
BGNE
-1.00
MRTX
-1.00
IOVA
-1.00
MDGL
-1.00
BPMC
-1.00
APLS
-1.00
ASND
-1.00
ADPT
-1.00
ISEE
-1.00
KRTX
-1.00
KNTE
-1.00
IKNA
-1.00
RPHM
-1.00
OCEA
-1.00
DAWN
-1.00
DNA
-1.00
Long Term Debt to Equity 0.00 14/18 BPMC}
1.09
DNA}
0.56
APLS}
0.44
ADPT}
0.37
ISEE}
0.20
MDGL}
0.15
IOVA}
0.09
BGNE}
0.06
CVAC}
0.05
MRTX}
0.04
IKNA}
0.03
KRTX}
0.01
RPHM}
0.01
RPRX}
0.00
KNTE}
0.00
OCEA}
0.00
DAWN}
0.00
ASND}
-3.45
Debt to Equity 0.00 14/18 BPMC
1.23
DNA
0.56
APLS
0.47
ADPT
0.41
BGNE
0.32
ISEE
0.20
IOVA
0.10
CVAC
0.06
IKNA
0.06
MRTX
0.05
KNTE
0.02
KRTX
0.01
RPHM
0.01
RPRX
0.00
MDGL
0.00
DAWN
0.00
OCEA
-0.13
ASND
-8.10
Burn Rate -4.47 17/18 DNA
8.30
BGNE
7.71
RPHM
6.58
APLS
6.27
ISEE
6.26
IKNA
3.97
KNTE
3.30
ASND
3.11
MDGL
2.08
IOVA
1.84
KRTX
1.61
MRTX
1.56
BPMC
1.10
ADPT
1.01
OCEA
0.00
CVAC
-1.49
RPRX
-4.47
DAWN
-11.45
Cash to Cap 0.07 11/18 IKNA
0.75
CVAC
0.74
DNA
0.73
RPHM
0.59
KNTE
0.46
DAWN
0.34
BGNE
0.13
APLS
0.12
IOVA
0.10
ISEE
0.08
RPRX
0.07
ASND
0.07
MRTX
0.06
MDGL
0.03
ADPT
0.03
BPMC
0.01
KRTX
0.01
OCEA
0.00
CCR 3.57 1/18 RPRX
3.57
ASND
2.28
DNA
2.10
CVAC
1.04
KNTE
1.02
KRTX
0.98
MRTX
0.89
IKNA
0.87
ADPT
0.85
IOVA
0.73
ISEE
0.72
MDGL
0.59
BPMC
0.24
OCEA
0.16
RPHM
0.00
DAWN
-0.13
BGNE
-0.45
APLS
-0.59
EV to EBITDA 36.17 1/18 RPRX}
36.17
DAWN}
27.54
CVAC}
1.04
ISEE}
-1.00
KNTE}
-1.00
OCEA}
-1.00
IKNA}
-1.87
RPHM}
-4.04
DNA}
-12.25
IOVA}
-18.09
MRTX}
-22.72
ADPT}
-39.32
APLS}
-46.24
MDGL}
-69.16
KRTX}
-96.25
BPMC}
-188.79
ASND}
-257.89
BGNE}
-379.98
EV to Revenue 5.78 11/18 KRTX
19006.33
MRTX
102.36
MDGL
92.73
IKNA
35.19
RPHM
35.00
DAWN
28.32
ASND
24.44
IOVA
17.74
BPMC
14.50
ADPT
7.24
RPRX
5.78
BGNE
5.61
APLS
4.62
DNA
3.10
CVAC
0.65
ISEE
-1.00
KNTE
-1.00
OCEA
-1.00